Andros Pharmaceuticals Co.,Ltd Stock

Equities

6917

TW0006917008

Pharmaceuticals

End-of-day quote Taipei Exchange 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
21.5 TWD +3.61% Intraday chart for Andros Pharmaceuticals Co.,Ltd -0.92% -13.65%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Dynamic Chart
1 day+3.61%
1 week-0.92%
Current month-0.23%
1 month-3.37%
3 months+5.65%
6 months-20.07%
Current year-13.65%
More quotes
1 week
20.45
Extreme 20.45
22.05
1 month
20.45
Extreme 20.45
22.75
Current year
19.80
Extreme 19.8
26.60
1 year
19.80
Extreme 19.8
39.60
3 years
19.80
Extreme 19.8
46.30
5 years
19.80
Extreme 19.8
46.30
10 years
19.80
Extreme 19.8
46.30
More quotes
Managers TitleAgeSince
Chief Executive Officer - 08-06-30
Chief Operating Officer - -
More insiders
Andros Pharmaceuticals Co Ltd is a Taiwan-based company mainly engaged in the research, design, development, manufacture and sales of novel drug delivery systems and liposome formulation-related products. The products are focused on topical drugs and are developed with a focus on pain-related indications. The Company is mainly engaged in the authorization of product technology transfer, as well as the manufacture and sales of niche generic drugs and high-end skin care products. Niche generic drugs and high-end skin care products include LALP Cream, which is used for anesthesia before minor skin surgery and laser treatment; iMinos Solution, which is used for the treatment of androgenetic alopecia; and deoxyribonucleic acid (DNA) repair enzyme liposome (LipoT4N5), which has anti-wrinkle, anti-sun and anti-aging effects. The products are mainly sold in Hong Kong and Taiwan.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW